Pasithea Therapeutics Files 8-K
Ticker: KTTAW · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1841330
| Field | Detail |
|---|---|
| Company | Pasithea Therapeutics CORP. (KTTAW) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, exhibits
TL;DR
Pasithea Therapeutics filed an 8-K on 6/20/25, mostly for exhibits.
AI Summary
On June 20, 2025, Pasithea Therapeutics Corp. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company is incorporated in Delaware and headquartered in Miami Beach, Florida.
Why It Matters
This 8-K filing indicates Pasithea Therapeutics Corp. is submitting required documentation to the SEC, which may contain updates on company events or financial information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for 'Other Events' and exhibits, without immediate disclosure of significant negative or positive events.
Key Numbers
- 001-40804 — SEC File Number (Identifier for Pasithea Therapeutics Corp.)
- 85-1591963 — IRS Employer Identification No. (Tax identification for Pasithea Therapeutics Corp.)
Key Players & Entities
- Pasithea Therapeutics Corp. (company) — Registrant
- June 20, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Miami Beach, Florida (location) — Principal executive offices
- 001-40804 (identifier) — SEC File Number
FAQ
What specific 'Other Events' are being reported by Pasithea Therapeutics Corp. in this 8-K?
The provided text does not detail the specific 'Other Events' beyond listing it as an item information category.
What is the significance of filing 'Financial Statements and Exhibits' on an 8-K?
This indicates the company is providing updated financial information or exhibits as required by the SEC, which could include material contracts, amendments, or other relevant documents.
When was Pasithea Therapeutics Corp. incorporated?
Pasithea Therapeutics Corp. was incorporated in Delaware.
What is the principal business address of Pasithea Therapeutics Corp.?
The principal executive offices are located at 1111 Lincoln Road, Suite 500, Miami Beach, Florida 33139.
What is the fiscal year end for Pasithea Therapeutics Corp.?
The fiscal year end for Pasithea Therapeutics Corp. is December 31st (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Pasithea Therapeutics Corp. (KTTAW).